215 related articles for article (PubMed ID: 28680150)
1. Virtual Screening, pharmacophore development and structure based similarity search to identify inhibitors against IdeR, a transcription factor of Mycobacterium tuberculosis.
Rohilla A; Khare G; Tyagi AK
Sci Rep; 2017 Jul; 7(1):4653. PubMed ID: 28680150
[TBL] [Abstract][Full Text] [Related]
2. Docking- and pharmacophore-based virtual screening for the identification of novel Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitor with a thiobarbiturate scaffold.
Zhang D; Lin Y; Chen X; Zhao W; Chen D; Gao M; Wang Q; Wang B; Huang H; Lu Y; Lu Y
Bioorg Chem; 2019 Apr; 85():229-239. PubMed ID: 30641319
[TBL] [Abstract][Full Text] [Related]
3. Molecular Informatics Studies of the Iron-Dependent Regulator (ideR) Reveal Potential Novel Anti-
Kwofie SK; Enninful KS; Yussif JA; Asante LA; Adjei M; Kan-Dapaah K; Tiburu EK; Mensah WA; Miller WA; Mosi L; Wilson MD
Molecules; 2019 Jun; 24(12):. PubMed ID: 31234337
[TBL] [Abstract][Full Text] [Related]
4. Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of
Kouman KC; Keita M; Kre N'Guessan R; Owono Owono LC; Megnassan E; Frecer V; Miertus S
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554227
[TBL] [Abstract][Full Text] [Related]
5. Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase.
Jung IP; Ha NR; Lee SC; Ryoo SW; Yoon MY
Int J Antimicrob Agents; 2016 Sep; 48(3):247-58. PubMed ID: 27451857
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Mycobacterium tuberculosis α-1,4-glucan branching enzyme (GlgB) inhibitors by structure- and ligand-based virtual screening.
Dkhar HK; Gopalsamy A; Loharch S; Kaur A; Bhutani I; Saminathan K; Bhagyaraj E; Chandra V; Swaminathan K; Agrawal P; Parkesh R; Gupta P
J Biol Chem; 2015 Jan; 290(1):76-89. PubMed ID: 25384979
[TBL] [Abstract][Full Text] [Related]
7. Structure-based virtual screening as a tool for the identification of novel inhibitors against Mycobacterium tuberculosis 3-dehydroquinate dehydratase.
Petersen GO; Saxena S; Renuka J; Soni V; Yogeeswari P; Santos DS; Bizarro CV; Sriram D
J Mol Graph Model; 2015 Jul; 60():124-31. PubMed ID: 26043661
[TBL] [Abstract][Full Text] [Related]
8. Discovery of New and Potent InhA Inhibitors as Antituberculosis Agents: Structure-Based Virtual Screening Validated by Biological Assays and X-ray Crystallography.
Kamsri P; Hanwarinroj C; Phusi N; Pornprom T; Chayajarus K; Punkvang A; Suttipanta N; Srimanote P; Suttisintong K; Songsiriritthigul C; Saparpakorn P; Hannongbua S; Rattanabunyong S; Seetaha S; Choowongkomon K; Sureram S; Kittakoop P; Hongmanee P; Santanirand P; Chen Z; Zhu W; Blood RA; Takebayashi Y; Hinchliffe P; Mulholland AJ; Spencer J; Pungpo P
J Chem Inf Model; 2020 Jan; 60(1):226-234. PubMed ID: 31820972
[TBL] [Abstract][Full Text] [Related]
9. Structural insight into Mycobacterium tuberculosis maltosyl transferase inhibitors: pharmacophore-based virtual screening, docking, and molecular dynamics simulations.
Sengupta S; Roy D; Bandyopadhyay S
J Biomol Struct Dyn; 2015; 33(12):2655-66. PubMed ID: 25669125
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
11. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
[TBL] [Abstract][Full Text] [Related]
12. Identification of
Singh S; Khare G; Bahal RK; Ghosh PC; Tyagi AK
Drug Des Devel Ther; 2018; 12():1065-1079. PubMed ID: 29750019
[TBL] [Abstract][Full Text] [Related]
13. Knowledge based identification of potent antitubercular compounds using structure based virtual screening and structure interaction fingerprints.
Kumar A; Chaturvedi V; Bhatnagar S; Sinha S; Siddiqi MI
J Chem Inf Model; 2009 Jan; 49(1):35-42. PubMed ID: 19063713
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium tuberculosis lysine-ɛ-aminotransferase a potential target in dormancy: Benzothiazole based inhibitors.
Reshma RS; Jeankumar VU; Kapoor N; Saxena S; Bobesh KA; Vachaspathy AR; Kolattukudy PE; Sriram D
Bioorg Med Chem; 2017 May; 25(10):2761-2771. PubMed ID: 28389113
[TBL] [Abstract][Full Text] [Related]
15. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR
ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832
[TBL] [Abstract][Full Text] [Related]
16. Virtual Screening of Small Molecular Inhibitors against DprE1.
Zhang G; Guo S; Cui H; Qi J
Molecules; 2018 Feb; 23(3):. PubMed ID: 29495447
[TBL] [Abstract][Full Text] [Related]
17. Virtual screening and synthesis of novel antitubercular agents through interaction-based pharmacophore and molecular docking studies.
Bhattarai D; Muddassar M; Jang JW; Hong SK; Kim EE; Oh T; Cho SN; Pae AN; Keum G
Curr Comput Aided Drug Des; 2014; 10(4):383-92. PubMed ID: 25872944
[TBL] [Abstract][Full Text] [Related]
18. Toward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosisl,d-transpeptidase 2.
Billones JB; Carrillo MC; Organo VG; Macalino SJ; Sy JB; Emnacen IA; Clavio NA; Concepcion GP
Drug Des Devel Ther; 2016; 10():1147-57. PubMed ID: 27042006
[TBL] [Abstract][Full Text] [Related]
19. Pyrrolidinone and pyrrolidine derivatives: Evaluation as inhibitors of InhA and Mycobacterium tuberculosis.
Matviiuk T; Madacki J; Mori G; Orena BS; Menendez C; Kysil A; André-Barrès C; Rodriguez F; Korduláková J; Mallet-Ladeira S; Voitenko Z; Pasca MR; Lherbet C; Baltas M
Eur J Med Chem; 2016 Nov; 123():462-475. PubMed ID: 27490025
[TBL] [Abstract][Full Text] [Related]
20. Identification of Mycobacterium tuberculosis CtpF as a target for designing new antituberculous compounds.
Santos P; Lopez-Vallejo F; Ramírez D; Caballero J; Mata Espinosa D; Hernández-Pando R; Soto CY
Bioorg Med Chem; 2020 Feb; 28(3):115256. PubMed ID: 31879181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
